We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

6 hedge funds and large institutions have $3M invested in Catheter Precision in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more capital invested

Capital invested by funds: $2.14M → $3M (+$855K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

25% less funds holding

Funds holding: 8 → 6 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$1.13M
2
Squarepoint
Squarepoint
New York
+$119K
3
Citadel Advisors
Citadel Advisors
Florida
+$59.5K
4
Renaissance Technologies
Renaissance Technologies
New York
+$59.5K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$283K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$119K
3
BLAM
Bourne Lent Asset Management
New York
-$61K
4
ACM
Alethea Capital Management
Washington
-$59.5K
5
UBS Group
UBS Group
Switzerland
-$59.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
1
Royce & Associates
New York
$1.51M +$1.13M +19 +950%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.05M +$59.5K +1 +7%
Squarepoint
3
Squarepoint
New York
$117K +$119K +2 New
Two Sigma Advisers
4
Two Sigma Advisers
New York
$116K -$119K -2 -50%
Citadel Advisors
5
Citadel Advisors
Florida
$93K +$59.5K +1 New
ACM
6
Alethea Capital Management
Washington
$92K -$59.5K -1 -50%
Osaic Holdings
7
Osaic Holdings
Arizona
$5K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$4K – – –
UBS Group
9
UBS Group
Switzerland
$3K -$59.5K -1 Closed
TSW
10
Thompson Siegel & Walmsley
Virginia
$2K – – –
Two Sigma Investments
11
Two Sigma Investments
New York
– -$283K -4 Closed
BLAM
12
Bourne Lent Asset Management
New York
– -$61K -1 Closed
BCM
13
Bridgeway Capital Management
Texas
– -$48K -1 Closed
AC
14
AlphaCore Capital
California
– -$15K – –
HighTower Advisors
15
HighTower Advisors
Illinois
– -$4K – –
Northern Trust
16
Northern Trust
Illinois
– -$4K – –
SWM
17
Sculati Wealth Management
Michigan
– -$15K – –
TC
18
Trilogy Capital
California
– -$14K – –
Vanguard Group
19
Vanguard Group
Pennsylvania
– -$27K – –
Victory Capital Management
20
Victory Capital Management
Texas
– -$3K – –
WC
21
Weil Company
California
– -$21K – –

VTAK Hedge Fund Activity: Q4 2020 in Review

6 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q4 2020, worth a combined $3M — up 40% from $2.14M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VTAK and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Royce & Associates, adding an estimated $1.13M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $283K sold.

  • 6 institutional investors held Catheter Precision (VTAK) as of Q4 2020, down from 8 in Q3 2020.
  • Funds reported $3M of Catheter Precision stock for Q4 2020, up 40% quarter-over-quarter.
  • 2 funds opened new Catheter Precision positions in Q4 2020 and 4 closed out, a net change of -2 holders.
  • The largest Catheter Precision buyer in Q4 2020 was Royce & Associates, an estimated $1.13M added.
  • The largest Catheter Precision seller in Q4 2020 was Two Sigma Investments, an estimated $283K sold.

Based on aggregated 13F filings for Q4 2020.